Today's linked article from the BBC shares progress from drug research that really could offer some hope. Apparently, researchers at a small UK pharmaceutical company, Destiny Pharma, are testing a product that treats the extremely drug resistant bug MRSA. Most importantly, though, even when the MRSA bacterium is exposed repeatedly to the drug concerned - which is actually applied as a nasal gel - it does not appear to develop resistance. Both the scientists and the UK government are cautiously optimistic about the research, but if product development continues to go well, the gel could be used in UK hospitals and elsewhere as early as 2011. (Image from BBC online.)
Sunday, May 18, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment